Chartwell Investment Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
Other funds holding SYNH
Chartwell Investment Partners's SYNH Position: Q4 2022 in Review
Chartwell Investment Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 59,168 shares — an estimated $2.79M sold.
Chartwell Investment Partners first reported a position in SYNH in Q4 2014 and held it in 17 quarters. The position peaked at $30M in Q1 2016. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.
- Chartwell Investment Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
- Chartwell Investment Partners sold 59,168 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $2.79M.
- Chartwell Investment Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 17 quarters.
- Chartwell Investment Partners's Syneos Health, Inc. Class A Common Stock position peaked at $30M in Q1 2016.
- 307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.
Based on Chartwell Investment Partners's 13F filing for Q4 2022, filed 16 Feb 2023.